CNTX

Context Therapeutics Inc

CNTX.US contexttherapeutics.com + Research + Basket
CIK 0001842952
Employees 15
Phone 267 225 7416
Fiscal year end December
IPO Oct 20, 2021
Address 2001 Market Street, Philadelphia, PA, United States, 19103
0.19
-0.02 (-7.67%)
USD · NASDAQ
52-week range
0.19
3.62
Trading at 0% of the 52-week range
Market Cap
18.70M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.42
Div. Yield
N/A
% Institutions
68.77%
% Insiders
1.57%

1 Year

-83.4%

3 Year

-84.7%

10 Year

-96.3%
Description

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Actions

Add an action for CNTX.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Martin A. Lehr Co-Founder, President, CEO & Director 1984
Ms. Jennifer Minai-Azary CFO & Treasurer 1978
Mr. Alex C. Levit Esq., J.D. Chief Legal Officer & Corporate Secretary 1979
Mr. Christopher Beck M.B.A. Senior Vice President of Operations NA
Mr. Jeffrey Liebman Associate Director of Accounting NA
Ms. Jennifer Dashnau M.B.A., Ph.D. Senior Vice President of Technical Operations NA
Dr. Karen Chagin M.D. Chief Medical Officer 1977

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jun 09, 2025 Martin A Lehr N/A Purchase 100.00K $0.70 $70.00K SEC
Jun 06, 2025 Alex C Levit N/A Purchase 20.00K $0.58 $11.60K SEC
Jun 06, 2025 Jennifer Lynn Minai-Azary N/A Purchase 40.01K $0.64 $25.61K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Deep Track Capital, LP 7.42M Jun 30, 2026 8.08% $0.06 0.00%
Nextech Invest, Ltd. 7.42M Jun 30, 2026 8.08% $0.20 0.00%
Soleus Capital Management, L.P. 7.06M Jun 30, 2026 7.69% $0.13 1.44%
BlackRock Inc 6.17M Jun 30, 2026 6.71% $0.00 628.63%
Avidity Partners Management LP 5.00M Jun 30, 2026 5.44% $0.44 -50.00%
Franklin Templeton Inc 3.80M Jun 30, 2026 4.14% $0.00 0.00%
Vanguard Capital Management, LLC 3.43M Jun 30, 2026 3.74% $0.00 0.00%
Octagon Capital Advisors LP 3.05M Jun 30, 2026 3.32% $0.15 -41.90%
Blue Owl Capital Holdings LP 2.93M Jun 30, 2026 3.19% $0.24 -42.35%
TCG Crossover Management, LLC 2.68M Jun 30, 2026 2.92% $0.04 0.00%
Geode Capital Management, LLC 1.83M Jun 30, 2026 1.99% $0.00 203.15%
State Street Corp 1.41M Jun 30, 2026 1.54% $0.00 505.30%
MPM Oncology Impact Management LP 1.30M Jun 30, 2026 1.41% $0.04 -87.84%
Renaissance Technologies Corp 1.04M Jun 30, 2026 1.13% $0.00 469.07%
Acadian Asset Management LLC 1.01M Jun 30, 2026 1.10% $0.00 0.00%
ADAR1 Capital Management LLC 750.97K Jun 30, 2026 0.82% $0.02 113.89%
Jane Street Group LLC 645.21K Jun 30, 2026 0.70% $0.00 47.67%
Vanguard Portfolio Management, LLC 638.88K Jun 30, 2026 0.70% $0.00 0.00%
Northern Trust Corp 615.58K Jun 30, 2026 0.67% $0.00 496.16%
Vanguard Fiduciary Trust Co 433.89K Jun 30, 2026 0.47% $0.00 27.11%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 2.82M 3.06% ▲ 0.00% Sep 30, 2026
2 iShares Russell 2000 ETF 2.28M 2.48% ▼ 0.41% Oct 29, 2026
3 Fidelity Small Cap Index 1.01M 1.10% ▼ 0.12% Jul 31, 2026
4 iShares Russell 2000 Growth ETF 888.30K 0.97% ▲ 0.25% Oct 29, 2026
5 Vanguard Russell 2000 ETF 533.66K 0.58% ▼ 1.26% Sep 30, 2026
6 Abante Quant Value FI 411.79K 0.45% ▲ 0.00% Aug 31, 2026
7 iShares Micro-Cap ETF 284.29K 0.31% ▲ 0.00% Oct 29, 2026
8 Calamos Market Neutral Income A 277.81K 0.30% ▲ 0.00% Jun 30, 2026
9 Fidelity Extended Market Index 276.57K 0.30% ▲ 10.88% Aug 31, 2026
10 Belfund SICAV Belinvest Equity A USD Acc 260.00K 0.28% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $18.70M
EBITDA: $-48.71M
Book Value: $0.42
Earnings/Share: $-0.48
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -45.70%
ROE (TTM): -76.14%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $-24.92M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 91.88M
Shares Float: 63.73M
% Insiders: 1.57%
% Institutions: 68.77%
Shares Short: 4.27M
Shares Short (Prior Month): 4.71M
Short Ratio: 4.12
Short % Float: 5.36%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-124.66K
Gross Profit
subtotal
$-124.66K
SG&A
adjust
$-7.85M
R&D
adjust
$-31.86M
Operating Income
subtotal
$-39.70M
Other / Non-Operating Items
adjust
$3.58M
Net Income
subtotal
$-36.12M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CNTX.US!